Haematologica, Vol 92, Issue 12, 1703-1706 doi:10.3324/haematol.11611
Copyright © 2007 by Ferrata Storti Foundation
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lijfering, W. M.
Right arrow Articles by van der Meer, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lijfering, W. M.
Right arrow Articles by van der Meer, J.

Thrombosis

The risk of venous and arterial thrombosis in hyperhomocysteinemic subjects may be a result of elevated factor VIII levels

Willem M. Lijfering, Nic J.G.M. Veeger, Jan-Leendert P. Brouwer, Jan van der Meer

From Division of Haemostasis, Thrombosis and Rheology, Department of Hematology (WML, JLPB, JvdM); Department of Epidemiology, University Medical Center Groningen, Groningen, The Netherlands (NJGMV)

Correspondence: Willem Lijfering, Division of Haemostasis, Thrombosis and Rheology, Department of Hematology, University Medical Center Groningen, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands. E-mail: w.lijfering{at}int.umcg.nl

In a large retrospective study of thrombophilic families, we analyzed 405 relatives of patients, hypothesizing that hyperhomocysteinemia and elevated factor VIII levels are closely related. Median factor VIII levels in hyperhomocysteinemic relatives were 169 IU/dL, compared with 136 IU/dL in normohomocysteinemic relatives (p =0.007), and were more often elevated (>150 IU/dL; p =0.006). Hyperhomocysteinemia was associated with an increased risk of venous and arterial thrombosis; relative risk (RR) 2.6 (CI 1.3–4.8) and 3.7 (CI 1.5–8.4) respectively. Relatives with elevated FVIII were also at risk; RR 2.3 (CI 1.4–4.0) for venous thrombosis and 2.3 (CI 1.0–5.1) for arterial thrombosis. After excluding all relatives with elevated factor VIII, RR for hyperhomocysteinemia and venous thrombosis dropped to 1.3 (CI 0.2–9.8) and no relatives had arterial thrombosis. We conclude that it is likely that the increased risk of venous and arterial thrombosis in hyperhomocysteinemia is mainly related to elevated FVIII levels.

Key words: thrombosis, hyperhomocysteinemia, factor VIII.




This article has been cited by other articles:


Home page
BloodHome page
W. M. Lijfering, J.-L. P. Brouwer, N. J. G. M. Veeger, I. Bank, M. Coppens, S. Middeldorp, K. Hamulyak, M. H. Prins, H. R. Buller, and J. van der Meer
Selective testing for thrombophilia in patients with first venous thrombosis: results from a retrospective family cohort study on absolute thrombotic risk for currently known thrombophilic defects in 2479 relatives
Blood, May 21, 2009; 113(21): 5314 - 5322.
[Abstract] [Full Text] [PDF]